Industry

Researchers at Friedrich-Alexander-Universität Erlangen-Nürnberg and Kinarus showed antiviral efficacy of KIN001 against SARS-CoV-2 and its variants of concern in vitro Interim data in Q3 for KINETIC, Phase 2 trial of KIN001 in hospitalized COVID-19 patients KINFAST Phase 2 trial of KIN001 in ambulatory COVID-19 patients to start this summer BASEL, Switzerland–(BUSINESS WIRE)–Kinarus Therapeutics Holding AG … [Read more…]

LONDON–(BUSINESS WIRE)–All Seas Capital Fund I (“All Seas Capital”), a pan-European private capital fund that provides flexible long-term financing solutions to leading mid cap companies, announces a growth investment in SoMeD Santé (“SoMeD” or the “Company”), a private medical centre group in France. SoMeD provides a multidisciplinary service, including GP, radiography and dental services, from … [Read more…]

Pfizer will invest €90.5 million in Valneva Planned Phase 3 study confirmed to initiate in Q3 2022 SAINT-HERBLAIN, France & NEW YORK–(BUSINESS WIRE)–Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and Pfizer Inc. (NYSE: PFE) today announced that they have entered into an Equity Subscription Agreement and have updated the terms of … [Read more…]

MILAN–(BUSINESS WIRE)–Deenova today disclosed that it expanded its market dominance in France with another net new UniHA competitive award for its D3 ACCED mechatronic solution at Centre Hospitalier de Mayotte in French overseas departments. Additionally, Deenova announced a new competitive tender win at GHPSO Creil & Senlis also for its market leading D3 ACCED mechatronic … [Read more…]

TOKYO–(BUSINESS WIRE)–Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) officially announced today that an organoarsenic drug “DARVIAS® Injection 135mg” (SP-02, hereinafter DARVIAS®) has been approved for relapsed or refractory Peripheral T-Cell Lymphoma (hereinafter “PTCL”) by the Ministry of Health, Labor and Welfare (MHLW). Solasia filed an NDA with … [Read more…]

Monkeypox Press Teleconference: Mon., 6/20 @ 11:00 am PT Reuters reports the World Health Organization (WHO) is now investigating reports that scientists have detected viral DNA in the semen of a handful of monkeypox patients in Italy and Germany; preliminary findings suggest the possibility, yet to be confirmed, that virus may also be sexually transmitted … [Read more…]

SEOUL, South Korea–(BUSINESS WIRE)–As the spread of COVID-19 has slowed down worldwide, the demand for skincare is expected to increase, and expectations for the rapid growth of the skincare market are also growing. Other countries such as the United States, United Kingdom, and Germany have already lifted the measures to wear masks outdoors, and there … [Read more…]

Parents or Legal Guardians Seeking COVID-19 Vaccines for Younger Children Can Schedule an Appointment Now for Vaccination as Early as Saturday, June 25 DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens will begin administering Pfizer and Moderna COVID-19 vaccines to children aged 3 years and older at select locations nationwide following FDA Emergency Use Authorization (EUA) and new guidance from … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the outcome of the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) meeting for pimavanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). The PDAC voted 9 to 3 that the evidence presented does not support a conclusion … [Read more…]

BURLINGTON, Ontario–(BUSINESS WIRE)–Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) announced today the results of voting at its annual meeting of shareholders held on June 17, 2022 (the “Meeting”). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders … [Read more…]